| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |